Coagulation
12 markers in this category
Antithrombin III (Activity)
Antithrombin III Activity testing assesses your most important natural anticoagulant. Including this in a thrombophilia screen provides critical information about inherited or acquired clotting risk.
Antithrombin III (Concentration)
Antithrombin III Concentration complements the activity test for comprehensive thrombophilia screening, classifying any deficiency to guide preventive care.
D-Dimer
D-Dimer is a sensitive marker of clotting activity. As part of a health assessment, it provides valuable information about fibrin turnover and thrombotic risk.
Factor V Leiden
Factor V Leiden is the most common inherited thrombophilia. This one-time genetic test provides lifelong information about your clotting risk.
Fibrinogen
Fibrinogen provides dual insight into clotting function and inflammatory status. Including it in a health panel delivers valuable cardiovascular risk information.
INR
INR standardises clotting assessment and is essential for warfarin monitoring. Including it in a health panel provides baseline coagulation and liver function information.
Lupus Anticoagulant
Lupus anticoagulant testing identifies one of the strongest predictors of thrombosis. Including it in a comprehensive screen provides critical clotting risk information.
PT (Prothrombin Time)
Prothrombin Time provides essential coagulation and liver function data. Including PT in a health panel supports comprehensive assessment.
Protein C (Activity)
Protein C Activity testing evaluates a critical component of your natural anticoagulant system. Proactive screening identifies deficiency before a thrombotic event occurs.
Protein S (Activity)
Protein S Activity testing assesses the cofactor system supporting natural anticoagulation. Proactive screening reveals deficiency before a thrombotic event.
Thrombin Time
Thrombin Time completes a comprehensive coagulation assessment by evaluating the final clotting step — fibrinogen to fibrin conversion.
aPTT
aPTT provides essential coagulation screening. As part of a preventive health panel, it helps identify clotting abnormalities before they become clinically significant.